Sit Down and Play India

Sponsor
University of Illinois at Chicago (Other)
Overall Status
Completed
CT.gov ID
NCT04167254
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH)
59
2
2
13.8
29.5
2.1

Study Details

Study Description

Brief Summary

To gather data essential to evaluate the acceptability and feasibility of a brief, health care-based program delivered in routine healthcare visits in low and low-middle income countries to promote positive parenting behaviors with the aim to support early child development.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Sit Down and Play
Phase 1

Study Design

Study Type:
Interventional
Actual Enrollment :
59 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Feasibility of Implementing Sit Down and Play in Routine Visits in India
Actual Study Start Date :
Feb 7, 2020
Actual Primary Completion Date :
Aug 18, 2020
Actual Study Completion Date :
Apr 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Sit Down and Play

Behavioral: Sit Down and Play
Brief health care-based program that aims to promote key parenting behaviors that promote early childhood development

No Intervention: Usual Care

Outcome Measures

Primary Outcome Measures

  1. Parenting Behaviors that Promote Early Childhood developme [1 month after second immunization visit]

    Key items from the UNICEF Multiple Indicator Cluster Surveys Early Childhood Development Module

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
Parents/legal guardians will be eligible if they:
  • Are over the age of 18 years

  • Have a child between 6 and 10 weeks

  • Are presenting to Deshnur and Murgod Primary Health Centers in Karnataka, India for a heatlh visit and

  • Self-identify as the "primary caregiver.

Exclusion Criteria:
Parents/legal guardians will be ineligible if they:
  • Are less than the age of 18 years

  • Have a child who is not between 6 and 10 weeks or

  • Have a child who is sick at the time of visit

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Illinois at Chicago Chicago Illinois United States 60612
2 Deshnur Primary Health Center Deshnur Karnataka India

Sponsors and Collaborators

  • University of Illinois at Chicago
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Investigators

  • Principal Investigator: Reshma Shah, University of Illinois at Chicago

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Reshma Shah, MD, Assistant Professor of Pediatrics, University of Illinois at Chicago
ClinicalTrials.gov Identifier:
NCT04167254
Other Study ID Numbers:
  • 2014-0337_4
First Posted:
Nov 18, 2019
Last Update Posted:
May 3, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of May 3, 2021